John M Leonard
CEO, President at Intellia Therapeutics, Inc. (NTLA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 24SEC | NTLAIntellia Therapeutics, Inc. | Sell Plan | 19,8901,149,849 held (−2%) | $12.60 | $251K | +3.7% |
| Aug 24SEC | NTLAIntellia Therapeutics, Inc. | Sell Plan | 2,7851,147,064 held (−0%) | $13.00 | $36K | +0.5% |
| Jan 7SEC | NTLAIntellia Therapeutics, Inc. | Sell | 34,1461,013,339 held (−3%) | $9.21 | $314K | +41.9% |
| Dec 12SEC | NTLAIntellia Therapeutics, Inc. | Sell Plan | 49,9591,077,115 held (−4%) | $9.49 | $474K | +37.7% |
| Dec 12SEC | NTLAIntellia Therapeutics, Inc. | Sell Plan | 32,8321,044,283 held (−3%) | $9.47 | $311K | +38.0% |
| Dec 12SEC | NTLAIntellia Therapeutics, Inc. | Sell Plan | 5,3551,038,928 held (−1%) | $9.59 | $51K | +36.3% |
- Sell
CEO, President John M Leonard sold $251K of NTLA at $12.60 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John M Leonard sold $36K of NTLA at $13.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John M Leonard sold $474K of NTLA at $9.49 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John M Leonard sold $311K of NTLA at $9.47 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John M Leonard sold $51K of NTLA at $9.59 — pre-scheduled 10b5-1 plan sale.